ZURICH (Reuters) -Sandoz on Monday announced a deal to buy Cimerli, a biosimilar drug to treat vision impairment and loss, from Coherus BioSciences Inc. for $170 million. The drug is …
Tag:
sandoz
-
-
By Ludwig Burger and Paul Arnold FRANKFURT (Reuters) – Sandoz plans to launch at least five additional biologic drugs, its CEO Richard Saynor said, as the generics drugs business of …
-
(Reuters) – Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc’s big selling arthritis treatment Humira, adding to U.S. competition for the drug that …
-
ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis wants to spin off later this year. Ghostine has been …
-
ZURICH (Reuters) – Pharmaceuticals company Novartis plans to close a Sandoz generics plant in Wilson, North Carolina, around the end of 2023, it said on Friday, citing inability to use …
-
By Natalie Grover LONDON (Reuters) – Novartis CEO Vas Narasimhan could struggle to woo investors to the listing of generics drugs business Sandoz, as weaker drug prices and jittery financial …